These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 7202546)

  • 41. Direct correlation between nitric oxide synthase II inducibility and metastatic ability of UV-2237 murine fibrosarcoma cells carrying mutant p53.
    Shi Q; Huang S; Jiang W; Kutach LS; Ananthaswamy HN; Xie K
    Cancer Res; 1999 May; 59(9):2072-5. PubMed ID: 10232590
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Radiation response of cell populations irradiated in situ and separated from a fibrosarcoma.
    Grdina DJ; Basic I; Guzzino S; Mason KA
    Radiat Res; 1976 Jun; 66(3):634-43. PubMed ID: 935350
    [No Abstract]   [Full Text] [Related]  

  • 43. Analysis of clonal evolution in a tumor consisting of pSV2neo-transfected mouse fibrosarcoma clones.
    Enoki Y; Niwa O; Yokoro K; Toge T
    Jpn J Cancer Res; 1990 Feb; 81(2):141-7. PubMed ID: 2110131
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Establishment and characterization of an in vitro clonogenic cell assay for the R-3327-At Copenhagen rat prostatic tumor.
    Rao BR; Nakeff A; Eaton C; Heston WD
    Cancer Res; 1978 Dec; 38(12):4431-9. PubMed ID: 214223
    [No Abstract]   [Full Text] [Related]  

  • 45. Characterization of two murine tumor sublines selected purely in vivo for specific metastatic patterns.
    Ryd W; Hagmar B; Erkell LJ
    Invasion Metastasis; 1986; 6(1):21-32. PubMed ID: 3941027
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Carcinogenesis in tissue culture 24: tumorigenicity and aggregate-forming capacity of mammalian cells in culture.
    Takaoka T; Katsuta H; Akatsuka T
    Jpn J Exp Med; 1975 Aug; 45(4):299-312. PubMed ID: 171466
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cellular heterogeneity in malignant tumors. The importance of clonal interaction on tumor evolution, response to chemotherapy and metastatic ability evaluated in experimental systems.
    Aabo K
    Dan Med Bull; 1996 Sep; 43(4):336-49. PubMed ID: 8884135
    [No Abstract]   [Full Text] [Related]  

  • 48. Stochastic model of metastases formation.
    Liotta LA; Saidel GM; Kleinerman J
    Biometrics; 1976 Sep; 32(3):535-50. PubMed ID: 963169
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Standard laboratory procedures for in vitro assay of human tumor stem cells.
    Soehnlen B; Young L; Liu R
    Prog Clin Biol Res; 1980; 48():331-8. PubMed ID: 7208523
    [No Abstract]   [Full Text] [Related]  

  • 50. Growth control and cell spreading: differential response in preneoplastic and in metastatic cell variants.
    Raz A; Ben-Ze'ev A
    Int J Cancer; 1982 Jun; 29(6):711-5. PubMed ID: 7107072
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Malignant properties and DNA content of daughter clones from a mouse fibrosarcoma: differentiation between malignant properties.
    Suzuki N; Williams M; Hunter NM; Withers HR
    Br J Cancer; 1980 Nov; 42(5):765-71. PubMed ID: 7459211
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Development of a clonogenic cell assay for human brain tumors.
    Rosenblum ML; Vasquez DA; Hoshino T; Wilson CB
    Cancer; 1978 Jun; 41(6):2305-14. PubMed ID: 657095
    [No Abstract]   [Full Text] [Related]  

  • 53. Colony growth in agar by human melanoma cells.
    Asano S; Riglar C
    Cancer Res; 1981 Mar; 41(3):1199-204. PubMed ID: 7459860
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Dynamics of tumor growth and cellular adaptation after inoculation into nude mice of varying numbers of transformed 3T3 cells and of readaptation to culture of the tumor cells.
    Rubin H; Chu BM; Arnstein P
    Cancer Res; 1986 Apr; 46(4 Pt 2):2027-34. PubMed ID: 3948178
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Correlation of in vitro growth properties and tumorigenicity of Syrian hamster cell lines.
    Barrett JC; Crawford BD; Mixter LO; Schechtman LM; Ts'o PO; Pollack R
    Cancer Res; 1979 May; 39(5):1504-10. PubMed ID: 427793
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Colony formation in agar by murine plasmacytoma cells: potentiation by hemopoietic cells and serum.
    Metcalf D
    J Cell Physiol; 1973 Jun; 81(3):397-410. PubMed ID: 4713720
    [No Abstract]   [Full Text] [Related]  

  • 57. Method for measurement of self-renewal capacity of clonogenic cells from biopsies of metastatic human malignant melanoma.
    Thomson SP; Meyskens FL
    Cancer Res; 1982 Nov; 42(11):4606-13. PubMed ID: 7127298
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Murine tumor cells metastasizing selectively in the liver: ability to produce hepatocyte-activating cytokines interleukin-1 and/or -6.
    Takeda K; Fujii N; Nitta Y; Sakihara H; Nakayama K; Rikiishi H; Kumagai K
    Jpn J Cancer Res; 1991 Nov; 82(11):1299-308. PubMed ID: 1752786
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Characterization of high- and low-metastatic clones derived from a methylcholanthrene-induced murine fibrosarcoma.
    Wang N; Yu SH; Liener IE; Hebbel RP; Eaton JW; McKhann CF
    Cancer Res; 1982 Mar; 42(3):1046-51. PubMed ID: 6174210
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Quantitative determination of disseminated tumor cells by [3H]thymidine incorporation in vitro and by agar colony formation.
    Schirrmacher V; Waller CA
    Cancer Res; 1982 Feb; 42(2):660-6. PubMed ID: 7034926
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.